Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
08 Oct 2016 ESMO 2016 Press Release: Targeting Estrogen Receptor Improves Progression-free Survival in Advanced Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
08 Oct 2016 ESMO 2016 Press Release: Niraparib Significantly Improves Outcome of Ovarian Cancer Patients in Landmark Trial Gynaecologic malignancies
08 Oct 2016 ESMO 2016 Press Release: Phase I Study of Novel Anti-Cancer Drug Uses Tumour mRNA Expression to Identify Responders Anticancer agents & Biologic therapy
07 Oct 2016 ESMO 2016 Press Release: Thousands of Melanoma Patients in Europe Have no Access to New Life Saving Drugs Melanoma and other skin tumours
07 Oct 2016 ESMO 2016 Press Release: Neoadjuvant Immunotherapy Prior to Surgery is Safe and Feasible in Early Lung Cancer Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
29 Sep 2016 FDA Modifies the Dosage Regimen for Currently Approved Indications for Nivolumab Genitourinary cancers - Melanoma and other skin tumours - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
28 Sep 2016 EU-US collaboration to boost medicine development for rare diseases Bioethics, legal and economic issues
27 Sep 2016 NICE Releases a Quality Standard in Skin Cancer Melanoma and other skin tumours
22 Sep 2016 EMA Recommends Granting a Marketing Authorisation for Edotreotide Imaging - Endocrine cancers
21 Sep 2016 EMA Recommends Granting a Conditional Marketing Authorisation for Ixazomib Haematologic malignancies - Anticancer agents & Biologic therapy
20 Sep 2016 EMA Recommends Granting a Conditional Marketing Authorisation for Olaratumab Sarcomas - Anticancer agents & Biologic therapy
19 Sep 2016 Press Release: Launch of First eUpdate Integrating Breakthroughs in ESMO Clinical Practice Guidelines
19 Sep 2016 EMA Recommends Granting a Marketing Authorisation for Palbociclib Breast cancer - Anticancer agents & Biologic therapy
16 Sep 2016 Start-Up of Human Cancer Models Initiative Translational research
15 Sep 2016 Niraparib Receives FDA Fast Track Designation for the Treatment of Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Gynaecologic malignancies - Anticancer agents & Biologic therapy